These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 3493622

  • 21. Granulocyte-colony stimulating factor is neuroprotective in a model of Parkinson's disease.
    Meuer K, Pitzer C, Teismann P, Krüger C, Göricke B, Laage R, Lingor P, Peters K, Schlachetzki JC, Kobayashi K, Dietz GP, Weber D, Ferger B, Schäbitz WR, Bach A, Schulz JB, Bähr M, Schneider A, Weishaupt JH.
    J Neurochem; 2006 May; 97(3):675-86. PubMed ID: 16573658
    [Abstract] [Full Text] [Related]

  • 22. Repeated administration of N-methyl-4-phenyl 1,2,5,6-tetrahydropyridine to rats is not toxic to striatal dopamine neurones.
    Boyce S, Kelly E, Reavill C, Jenner P, Marsden CD.
    Biochem Pharmacol; 1984 Jun 01; 33(11):1747-52. PubMed ID: 6610420
    [Abstract] [Full Text] [Related]

  • 23. Persistent depletion of striatal dopamine in mice by m-hydroxy-MPTP.
    Fuller RW, Hemrick-Luecke SK.
    Res Commun Chem Pathol Pharmacol; 1986 Aug 01; 53(2):167-72. PubMed ID: 3764080
    [Abstract] [Full Text] [Related]

  • 24. Does paraquat (PQ) mimic MPP+ toxicity?
    Woolley DE, Gietzen DW, Gee SJ, Magdalou J, Hammock BD.
    Proc West Pharmacol Soc; 1989 Aug 01; 32():191-3. PubMed ID: 2789384
    [No Abstract] [Full Text] [Related]

  • 25. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in mice is enhanced by pretreatment with diethyldithiocarbamate.
    Corsini GU, Pintus S, Chiueh CC, Weiss JF, Kopin IJ.
    Eur J Pharmacol; 1985 Dec 10; 119(1-2):127-8. PubMed ID: 3002815
    [No Abstract] [Full Text] [Related]

  • 26. Neuromelanin: a role in MPTP-induced neurotoxicity.
    D'Amato RJ, Alexander GM, Schwartzman RJ, Kitt CA, Price DL, Snyder SH.
    Life Sci; 1987 Feb 23; 40(8):705-12. PubMed ID: 2880274
    [Abstract] [Full Text] [Related]

  • 27. 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine destroys dopamine neurons in explants of rat embryo mesencephalon.
    Mytilineou C, Cohen G.
    Science; 1984 Aug 03; 225(4661):529-31. PubMed ID: 6610939
    [Abstract] [Full Text] [Related]

  • 28. Cocaine blocks the dopamine depletion induced by MPTP.
    Mayer RA, Jarvis MF, Wagner GC.
    Res Commun Chem Pathol Pharmacol; 1985 Jul 03; 49(1):145-8. PubMed ID: 3875884
    [Abstract] [Full Text] [Related]

  • 29. Neuroprotective effects of genistein on dopaminergic neurons in the mice model of Parkinson's disease.
    Liu LX, Chen WF, Xie JX, Wong MS.
    Neurosci Res; 2008 Feb 03; 60(2):156-61. PubMed ID: 18054104
    [Abstract] [Full Text] [Related]

  • 30. Differential neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in Swiss-Webster mice from different sources.
    Heikkila RE.
    Eur J Pharmacol; 1985 Oct 29; 117(1):131-3. PubMed ID: 3878793
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Dehydroepiandrosterone (DHEA) such as 17beta-estradiol prevents MPTP-induced dopamine depletion in mice.
    D'Astous M, Morissette M, Tanguay B, Callier S, Di Paolo T.
    Synapse; 2003 Jan 29; 47(1):10-4. PubMed ID: 12422368
    [Abstract] [Full Text] [Related]

  • 33. Neuroprotective effect of arundic acid, an astrocyte-modulating agent, in mouse brain against MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity.
    Himeda T, Kadoguchi N, Kamiyama Y, Kato H, Maegawa H, Araki T.
    Neuropharmacology; 2006 Mar 29; 50(3):329-44. PubMed ID: 16303147
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Studies on species sensitivity to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Part 2: Central administration of 1-methyl-4-phenylpyridinium.
    Giovanni A, Sonsalla PK, Heikkila RE.
    J Pharmacol Exp Ther; 1994 Sep 29; 270(3):1008-14. PubMed ID: 7932148
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induced dopamine D2 receptor hypersensitivity in the mouse is transient.
    Peroutka SJ, DeLanney L, Irwin I, Ison PJ, Ricaurte G, Schlegel JR, Langston JW.
    Res Commun Chem Pathol Pharmacol; 1985 May 29; 48(2):163-71. PubMed ID: 3875136
    [Abstract] [Full Text] [Related]

  • 38. Characterization of the neurotoxic potential of m-methoxy-MPTP and the use of its N-ethyl analogue as a means of avoiding exposure to a possible Parkinsonism-causing agent.
    Zimmerman DM, Cantrell BE, Reel JK, Hemrick-Luecke SK, Fuller RW.
    J Med Chem; 1986 Aug 29; 29(8):1517-20. PubMed ID: 3488406
    [Abstract] [Full Text] [Related]

  • 39. Peripheral effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and its main metabolite 1-methyl-4-phenylpyridinium ion (MPP+) in the rat.
    Algeri S, Ambrosio S, Garofalo P, Gerli P.
    Eur J Pharmacol; 1987 Sep 11; 141(2):309-12. PubMed ID: 3500067
    [Abstract] [Full Text] [Related]

  • 40. Evidence for a dissociation between MPTP toxicity and tyrosinase activity based on congenic mouse strain susceptibility.
    Hofele K, Sedelis M, Auburger GW, Morgan S, Huston JP, Schwarting RK.
    Exp Neurol; 2001 Mar 11; 168(1):116-22. PubMed ID: 11170726
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.